Eli Lilly (LLY)

• Market cap: $846B
• 1 day: -2.72%
• 5 days: -1.2%
• 1 month: -0.51%
• 3 months: -9.21%
• 6 months: -1.88%
• Year to date: -12.21%
• 1 year: 26.22%
• 5 years: 386.98%
• 10 years: 1,154.73%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 50,000